Standout Papers
Citation Impact
Citing Papers
Global phosphorylation analysis of β-arrestin–mediated signaling downstream of a seven transmembrane receptor (7TMR)
2010 StandoutNobel
Topological control of cytokine receptor signaling induces differential effects in hematopoiesis
2019 StandoutScienceNobel
A unique mechanism of β-blocker action: Carvedilol stimulates β-arrestin signaling
2007 StandoutNobel
β-Arrestin-mediated Signaling Regulates Protein Synthesis
2008 StandoutNobel
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies
2010 Standout
Arresting a Transient Receptor Potential (TRP) Channel
2010 StandoutNobel
β-Arrestin-2 Mediates Anti-apoptotic Signaling through Regulation of BAD Phosphorylation
2009 StandoutNobel
Collateral circulation
2008
Intracoronary and Intravenous Administration of Basic Fibroblast Growth Factor: Myocardial and Tissue Distribution
1999
Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb.
1998
Discoveries in structure and physiology of mechanically activated ion channels
2020 StandoutNatureNobel
Surviving ischemia: adaptive responses mediated by hypoxia-inducible factor 1
2000 StandoutNobel
Independent β-Arrestin2 and Gq/Protein Kinase Cζ Pathways for ERK Stimulated by Angiotensin Type 1A Receptors in Vascular Smooth Muscle Cells Converge on Transactivation of the Epidermal Growth Factor Receptor
2009 StandoutNobel
Ca2+ channels and skeletal muscle diseases
2010
The FGF family: biology, pathophysiology and therapy
2009 Standout
Downregulation of CXCR4 Gene Expression in Primary Human Endothelial Cells Following Infection with E1−E4+ Adenovirus Gene Transfer Vectors
2000
Calcium's Role in Mechanotransduction during Muscle Development
2014 Standout
Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis
2005
Prospects for Cardiovascular Research
2001 StandoutNobel
The TRPC3 Channel Has a Large Internal Chamber Surrounded by Signal Sensing Antennas
2006
First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer
2014 Standout
Vascular endothelial growth factor enhances atherosclerotic plaque progression
2001
β-Arrestin-biased Agonism at the β2-Adrenergic Receptor
2007 StandoutNobel
Transient receptor potential channelopathies
2010
Lymphangiogenesis: Molecular Mechanisms and Future Promise
2010 Standout
Cardiac hypertrophy in chronically anemic fetal sheep: Increased vascularization is associated with increased myocardial expression of vascular endothelial growth factor and hypoxia-inducible factor 1
1998 StandoutNobel
Insights from Angiogenesis Trials Using Fibroblast Growth Factor for Advanced Arteriosclerotic Disease
2003
Quantifying Ligand Bias at Seven-Transmembrane Receptors
2011 StandoutNobel
Angiogenesis in ischemic heart disease
1997
Canonical Transient Receptor Potential Channels Promote Cardiomyocyte Hypertrophy through Activation of Calcineurin Signaling
2006
Angiogenesis in cancer and other diseases
2000 StandoutNature
Temperature-dependent STIM1 activation induces Ca2+ influx and modulates gene expression
2011 StandoutNobel
Recent developments in biased agonism
2013 Nobel
Angiogenesis and lymphangiogenesis and expression of lymphangiogenic factors in the atherosclerotic intima of human coronary arteries
2005
Therapeutic potential of β-arrestin- and G protein-biased agonists
2010 StandoutNobel
Enhancement of cardiac function after adenoviral-mediated in vivo intracoronary β2-adrenergic receptor gene delivery
1999 StandoutNobel
Treating ALK-positive lung cancer—early successes and future challenges
2012
Pharmacokinetics and Pharmacodynamics of Recombinant FGF‐2 in a Phase I Trial in Coronary Artery Disease
2001
STIMulating store-operated Ca2+ entry
2009
Impaired cerebral cortex development and blood pressure regulation in FGF-2-deficient mice
1998
Regulation of angiogenesis by hypoxia: role of the HIF system
2003 StandoutNobel
Angiogenesis in life, disease and medicine
2005 StandoutNature
Cation channels of the transient receptor potential superfamily: Their role in physiological and pathophysiological processes of smooth muscle cells
2006
A β-arrestin 2 Signaling Complex Mediates Lithium Action on Behavior
2008 StandoutNobel
Testing clinical therapeutic angiogenesis using basic fibroblast growth factor (FGF‐2)
2003
Structure of the TRPV1 ion channel determined by electron cryo-microscopy
2013 StandoutNatureNobel
Teaching old receptors new tricks: biasing seven-transmembrane receptors
2010 StandoutNobel
Piezo channels and GsMTx4: Two milestones in our understanding of excitatory mechanosensitive channels and their role in pathology
2017
NFAT activation by membrane potential follows a calcium pathway distinct from other activity-related transcription factors in skeletal muscle cells
2008
Basic fibroblast growth factor in patients with intermittent claudication: results of a phase I trial
2000
Therapeutic angiogenesis in cardiology using protein formulations
2001
Impaired collateral vessel development in diabetes: potential cellular mechanisms and therapeutic implications
2001
β-Arrestin1 mediates nicotinic acid–induced flushing, but not its antilipolytic effect, in mice
2009 StandoutNobel
SWELL1, a Plasma Membrane Protein, Is an Essential Component of Volume-Regulated Anion Channel
2014 StandoutNobel
Canonical TRP channels and mechanotransduction: from physiology to disease states
2010
Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia-inducible factor 1α
1999 StandoutNobel
Cardiovascular gene therapy
2000
Basic and Therapeutic Aspects of Angiogenesis
2011 Standout
Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1α
1998 StandoutNobel
Transient Receptor Potential Cation Channels in Disease
2007 Standout
Physiologic and cardiac roles of β-arrestins
2008
Molecular mechanisms and clinical applications of angiogenesis
2011 StandoutNature
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice
2002 StandoutNobel
Immunodeficiency due to mutations in ORAI1 and STIM1
2010
Quantitative Phosphoproteomics Dissection of Seven-transmembrane Receptor Signaling Using Full and Biased Agonists
2010
Angiogenesis as a therapeutic target
2005 StandoutNature
Therapeutic Angiogenesis With Intramuscular NV1FGF Improves Amputation-free Survival in Patients With Critical Limb Ischemia
2008
Multifactorial basis for coronary collateralization: a complex adaptive response to ischemia
1999
β-Arrestin2 mediates the initiation and progression of myeloid leukemia
2012 StandoutNobel
Angiogenesis
2005
Direct in vivo gene transfer to canine myocardium using a replication-deficient adenovirus vector
1996
Distinct conformational changes in β-arrestin report biased agonism at seven-transmembrane receptors
2008 StandoutNobel
Molecular Mechanisms of Coronary Collateral Vessel Growth
1996
Hypoxia-inducible factor 1α protein expression is controlled by oxygen-regulated ubiquitination that is disrupted by deletions and missense mutations
2000 StandoutNobel
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice
2002 StandoutNobel
Hair Loss and Defective T- and B-Cell Function in Mice Lacking ORAI1
2008
Calcium‐dependent deceleration of the cell cycle in muscle cells by simulated microgravity
2013
Adaptive and Maladaptive Cardiorespiratory Responses to Continuous and Intermittent Hypoxia Mediated by Hypoxia-Inducible Factors 1 and 2
2012 StandoutNobel
β-arrestin- but not G protein-mediated signaling by the “decoy” receptor CXCR7
2009 StandoutNobel
Vessel Cooption, Regression, and Growth in Tumors Mediated by Angiopoietins and VEGF
1999 StandoutScience
Tissue Engineering--Current Challenges and Expanding Opportunities
2002 StandoutScience
Activation of STIM1-Orai1 Involves an Intramolecular Switching Mechanism
2010
Angiogenic Gene Therapy (AGENT) Trial in Patients With Stable Angina Pectoris
2002
Beta-Arrestin-Mediated Signaling in the Heart
2008
Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial
2002
β-Arrestin-biased ligands at seven-transmembrane receptors
2007 StandoutNobel
Calcineurin‐dependent cardiomyopathy is activated by TRPC in the adult mouse heart
2006
Functional Upregulation of the Vascular Endothelial Growth Factor Receptor KDR by Hypoxia
1996
Tie2 Expression and Phosphorylation in Angiogenic and Quiescent Adult Tissues
1997
Continuous liquid interface production of 3D objects
2015 StandoutScience
Delivery Strategies to Achieve Therapeutic Myocardial Angiogenesis
2000
Synergistic effect of HIF-1α gene therapy and HIF-1-activated bone marrow-derived angiogenic cells in a mouse model of limb ischemia
2009 StandoutNobel
Local Monocyte Chemoattractant Protein-1 Therapy Increases Collateral Artery Formation in Apolipoprotein E–Deficient Mice but Induces Systemic Monocytic CD11b Expression, Neointimal Formation, and Plaque Progression
2003
Adenoviral transfer of HIF-1α enhances vascular responses to critical limb ischemia in diabetic mice
2009 StandoutNobel
Selective engagement of G protein coupled receptor kinases (GRKs) encodes distinct functions of biased ligands
2009 StandoutNobel
HIF-1 and human disease: one highly involved factor
2000 StandoutNobel
Regulation of transient receptor potential canonical channel 1 (TRPC1) by sphingosine 1-phosphate in C2C12 myoblasts and its relevance for a role of mechanotransduction in skeletal muscle differentiation
2009
Therapeutic Angiogenesis and Vasculogenesis for Ischemic Disease
2004
Scaffold-Based Three-Dimensional Human Fibroblast Culture Provides a Structural Matrix That Supports Angiogenesis in Infarcted Heart Tissue
2001
Pharmacological Treatment of Coronary Artery Disease With Recombinant Fibroblast Growth Factor-2
2002
Engineering Complex Tissues
2012
Works of Jonathan A. Stiber being referenced
TRPC1 Channels Are Critical for Hypertrophic Signaling in the Heart
2009
Asymptomatic Profound Sinus Bradycardia (Heart Rate ≤45) in Non-small Cell Lung Cancer Patients Treated with Crizotinib
2011
STIM1 signalling controls store-operated calcium entry required for development and contractile function in skeletal muscle
2008
Effects of a single intracoronary injection of basic fibroblast growth factor in stable angina pectoris
2000
Intracoronary basic fibroblast growth factor enhances myocardial collateral perfusion in dogs
2000
Effect of Basic Fibroblast Growth Factor on Myocardial Angiogenesis in Dogs With Mature Collateral Vessels
1997
Mechanosensitive Channels in Striated Muscle and the Cardiovascular System: Not Quite a Stretch Anymore
2009
Pharmacodynamics of basic fibroblast growth factor: route of administration determines myocardial and systemic distribution
1997
Homer modulates NFAT-dependent signaling during muscle differentiation
2005
Mice Lacking Homer 1 Exhibit a Skeletal Myopathy Characterized by Abnormal Transient Receptor Potential Channel Activity
2008
Comparative Effects of Basic Fibroblast Growth Factor and Vascular Endothelial Growth Factor on Coronary Collateral Development and the Arterial Response to Injury
1996
TRPC3 channels confer cellular memory of recent neuromuscular activity
2004
β-Arrestin2-mediated inotropic effects of the angiotensin II type 1A receptor in isolated cardiac myocytes
2006 StandoutNobel
Effects of Chronic Systemic Administration of Basic Fibroblast Growth Factor on Collateral Development in the Canine Heart
1995